Editas Medicine, Inc.
Minimal political surface area biotech with zero lobbying, government contracts, insider activity, or recent congressional trades.
BusinessWhat EDIT does
Editas Medicine, Inc. (EDIT) is a biotechnology company in the healthcare sector.
12 months past · 3 months futureEDIT activity timeline
Lifetime Government AwardsEDIT federal contracts
EDIT doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding EDIT
Congressional TradesWho in Congress is trading EDIT
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Political ProfileWhere EDIT sits in Washington
No lobbying spend, donations, or influence patterns per get_political_influence (score 0). No recent congressional trades per get_sector_political_positioning (0 buys/sells since 2024-04-29).
Live signals + predictions for EDIT — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades EDIT
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord